NCT07452276

Brief Summary

This study would answer the following question:Does AI application-based training improve cognitive function in Patients with Stroke? The aims of this study: To investigate the efficacy of AI application-based training on cognitive function in stroke patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

February 19, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 5, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2026

Completed
Last Updated

March 5, 2026

Status Verified

January 1, 2026

Enrollment Period

1 month

First QC Date

February 19, 2026

Last Update Submit

March 1, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Cognitive Function

    Change in Global Cognitive Function Measured by the Montreal Cognitive Assessment (MoCA) Global cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA), a one-page, 30-point cognitive screening tool that evaluates attention, memory, executive function, language, visuospatial abilities, abstraction, calculation, and orientation. The test takes approximately 10 minutes to administer. Scores range from 0 to 30, with higher scores indicating better cognitive function. A score of less than 26 indicates cognitive impairment.

    Baseline and 6 weeks post-intervention

Study Arms (2)

AI-Based Cognitive Training

EXPERIMENTAL

Participants receive artificial intelligence-based cognitive training in stroke patients. The AI program is designed to target multiple cognitive domains including attention, memory, executive function, and processing speed.

Device: cognifit Mobile Application for Cognitive Training

Conventional Physical Therapy

ACTIVE COMPARATOR

Participants receive a conventional rehabilitation program consisting of aerobic exercises, relaxation exercises, and traditional paper-based cognitive exercises, in addition to standard physical therapy.

Behavioral: Conventional Cognitive Rehabilitation

Interventions

A structured artificial intelligence-based cognitive training program targeting attention, memory, executive function, and processing speed in patients with stroke. The program provides adaptive, individualized exercises based on participant performance.

AI-Based Cognitive Training

A structured conventional rehabilitation program consisting of aerobic exercises, relaxation exercises, and traditional paper-based cognitive exercises for patients with stroke. The duration and frequency of treatment are matched to the experimental group.

Conventional Physical Therapy

Eligibility Criteria

Age45 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patient's age will range from 45- 60 years.
  • Diagnosis of stroke in the chronic stage (≥3 months post-onset).
  • Presence of cognitive impairment confirmed by a Montreal Cognitive Assessment (MoCA) score ≤ 26.
  • Medically stable and able to follow instructions.
  • patients with memory deficits following stroke

You may not qualify if:

  • \- Patients will be excluded if they have:
  • Severe visual, hearing, or speech impairments prevent participation.
  • History of other neurological or psychiatric disorders.
  • Unstable cardiovascular or systemic disease.
  • Severe depression (Beck Depression Inventory \> 29).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physical therapy- Cairo University

Cairo, Egypt, 62517, Egypt

RECRUITING

MeSH Terms

Conditions

Stroke

Interventions

Cognitive Training

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Central Study Contacts

Omima Alaa Eldin Hussein

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 19, 2026

First Posted

March 5, 2026

Study Start

January 1, 2026

Primary Completion

February 1, 2026

Study Completion

June 6, 2026

Last Updated

March 5, 2026

Record last verified: 2026-01

Locations